Log in or Sign up for Free to view tailored content for your specialty!
Gynecologic Cancer News
FDA grants breakthrough therapy designation to combination for recurrent ovarian cancer
The FDA granted breakthrough therapy designation to VS-6766 with defactinib for treatment of recurrent low-grade serous ovarian cancer, according to the agents’ manufacturer.
Atezolizumab regimen fails to extend PFS in newly diagnosed ovarian cancer
The addition of atezolizumab to chemotherapy and bevacizumab failed to significantly prolong PFS for women with newly diagnosed stage III or stage IV epithelial ovarian cancer, according to a phase 3 study in Journal of Clinical Oncology.
Log in or Sign up for Free to view tailored content for your specialty!
Cervical cancer incidence declines as rates of other HPV-associated cancers rise
Incidence of cervical cancer declined as rates of other HPV-associated cancers increased significantly in the U.S. from 2001 to 2017, according to a population-based study of trends presented during the virtual ASCO Annual Meeting.
Pre-COVID-19 data show ‘suboptimal’ rates of cancer prevention, early detection in US
Despite historic lows in smoking prevalence, rates of cancer prevention and early detection remained suboptimal in the U.S. between 2018 and 2019, according to a study by researchers at American Cancer Society.
Documentary aims to expose gender inequality, need for reform in surgical field
An upcoming documentary film, “1001 Cuts,” aims to show the operating room through the eyes of female surgeons and expose the gender discrimination they face every day.
FDA grants priority review to Keytruda-Lenvima combination for kidney, endometrial cancers
The FDA granted priority review to pembrolizumab plus lenvatinib for treatment of advanced renal cell carcinoma and advanced endometrial carcinoma, according to the agents’ manufacturers.
Adavosertib monotherapy active in recurrent uterine serous carcinoma
Adavosertib demonstrated clinical activity among women with recurrent uterine serous carcinoma, according to results of a phase 2 study published in Journal of Clinical Oncology.
Clinical, neuropsychological factors influence chemotherapy-induced nausea severity
Chemotherapy-induced nausea remains a significant clinical problem, but severity varies based on multiple factors, according to results presented during the virtual Oncology Nursing Society Congress.
Researcher develops novel sensor for early detection of ovarian cancer
Mijin Kim, PhD, has been selected to receive a 2021 Marie-Josée Kravis Women in Science Endeavor fellowship grant for her work on a novel sensor technology designed for early detection of ovarian cancer.
Growing focus on patients’ mental health appears to lower suicidality, improve cancer outcomes
During the past 2 decades, addressing the psychosocial needs of patients with cancer has become recognized as a crucial component of treatment, but experts said work remains to fully integrate mental health into routine cancer care.